peo cu lidocaină 1 g pulbere şi solvent pentru soluţie injectabilă
gm pharmaceuticals ltd. - ceftriaxonum - pulbere şi solvent pentru soluţie injectabilă - 1 g
peo 1 g pulbere pentru soluţie injectabilă/perfuzabilă
gm pharmaceuticals ltd. - ceftriaxonum - pulbere pentru soluţie injectabilă/perfuzabilă - 1 g
sefabel 0,5 g pulbere şi solvent pentru soluţie injectabilă
nobel ilac pazarlama ve sanayii ltd. Şti - ceftriaxonum - pulbere şi solvent pentru soluţie injectabilă - 0,5 g
sefabel 1 g pulbere şi solvent pentru soluţie injectabilă
nobel ilac pazarlama ve sanayii ltd. Şti - ceftriaxonum - pulbere şi solvent pentru soluţie injectabilă - 1 g
zometa solutie perfuzabila 4 mg/100 ml
novartis pharma ag - acid zoledronicum - solutie perfuzabila - 4 mg/100 ml
zoledronic acid teva pharma
teva b.v. - acid zoledronic - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - medicamente pentru tratamentul bolilor osoase - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. tratamentul de boala paget osoase la adulți.
celdron™ liofilizat pentru solutie injectabila 4 mg
celon laboratories limited - acid zoledronicum - liofilizat pentru solutie injectabila - 4 mg
acid ibandronic 1mg/ml concentrat pentru soluţie perfuzabilă
accord healthcare limited - acid ibandronicum - concentrat pentru soluţie perfuzabilă - 1mg/ml
teriparatide sun
sun pharmaceutical industries europe b.v. - teriparatidul - osteoporosis; osteoporosis, postmenopausal - homeostazia de calciu - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
exoderil set 50 mg/ml
stradis - franta - amorolfinum - lac de unghii medicamentos - 50mg/ml - antifungice de uz dermatologic alte antifungice de uz dermatologic